Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America

Next-generation sequencing (NGS) is progressively being used in clinical practice. However, several barriers preclude using this technology for precision oncology in most Latin American countries. To overcome some of these barriers, we have designed a 25-gene panel that contains predictive biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvo, Mauricio, González-Feliú, Evelin, Toro, Jessica, Gallegos, Iván, Maureira, Ignacio, Miranda-González, Nicolás, Barajas, Olga, Bustamante, Eva, Ahumada, Mónica, Colombo, Alicia, Armisén, Ricardo, Villamán, Camilo, Ibañez, Carolina, Bravo, María Loreto, Sanhueza, Verónica, Spencer, M. Loreto, de Toro, Gonzalo, Morales, Erik, Bizama, Carolina, García, Patricia, Carrasco, Ana María, Gutiérrez, Lorena, Bermejo, Justo Lorenzo, Verdugo, Ricardo A., Marcelain, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472524/
https://www.ncbi.nlm.nih.gov/pubmed/34575676
http://dx.doi.org/10.3390/jpm11090899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472524/
https://www.ncbi.nlm.nih.gov/pubmed/34575676
http://dx.doi.org/10.3390/jpm11090899

Ejemplares similares